expanded
-
Hospitals
Zimmer Biomet Announces FDA Approval of Expanded 26-week Efficacy Claim for Gel-One® Cross-Linked Hyaluronate for Treatment of Pain Associated with Knee Osteoarthritis
WARSAW, Ind., Feb. 1, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced that the U.S. Food…
Read More » -
Financial
Episurf Medical receives expanded reimbursement coverage in the UK, Netherlands and Belgium
In line with Episurf Medical’s plan to achieve private health sector reimbursement, the Episealer® procedure and products have been approved…
Read More »